[1]
|
Qin, J., Li, R., Raes, J., et al. (2010) A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing. Nature, 464, 59-65.
https://doi.org/10.1038/nature08821
|
[2]
|
Zhu, B., Wang, X. and Li, L. (2010) Human Gut Microbiome: The Second Genome of Human Body. Protein Cell, 1, 718-725.
https://doi.org/10.1007/s13238-010-0093-z
|
[3]
|
Biragyn, A. and Ferrucci, L. (2018) Gut Dysbiosis: A Potential Link between Increased Cancer Risk in Ageing and Inflammaging. The Lancet Oncology, 19, e295-e304.
https://doi.org/10.1016/S1470-2045(18)30095-0
|
[4]
|
Maynard, C.L., Elson, C.O., Hatton, R.D., et al. (2012) Reciprocal Interactions of the Intestinal Microbiota and Immune System. Nature, 489, 231-241.
https://doi.org/10.1038/nature11551
|
[5]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[6]
|
Lacey, J.V., Kreimer, A.R., Buys, S.S., et al. (2009) Breast Cancer Epidemiology According to Recognized Breast Cancer Risk Factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer, 9, 84.
https://doi.org/10.1186/1471-2407-9-84
|
[7]
|
Shapira, I., Sultan, K., Lee, A., et al. (2013) Evolving Concepts: How Diet and the Intestinal Microbiome Act as Modulators of Breast Malignancy. ISRN Oncology, 2013, Article ID: 693920. https://doi.org/10.1155/2013/693920
|
[8]
|
Mineli, E.B., Beghini, A.M., Vesentini, S., et al. (1990) Intestinal Microflora as an Alternative Metabolic Source of Estrogens in Women with Uterine Leiomyoma and Breast Cancer. Annals of the New York Academy of Sciences, 595, 473-479.
https://doi.org/10.1111/j.1749-6632.1990.tb34337.x
|
[9]
|
Buchta Rosean, C., Bostic, R.R., Ferey, J.C.M., et al. (2019) Preexisting Commensal Dysbiosis Is a Host-Intrinsic Regulator of Tissue Inflammation and Tumor Cell Dissemination in Hormone Receptor-Positive Breast Cancer. Cancer Research, 79, 3662-3675. https://doi.org/10.1158/0008-5472.CAN-18-3464
|
[10]
|
Goedert, J.J., Jones, G., Hua, X., et al. (2015) Investigation of the Association between the Fecal Microbiota and Breast Cancer in Postmenopausal Women: A Population-Based Case-Control Pilot Study. Journal of the National Cancer Institute, 107, djv147. https://doi.org/10.1093/jnci/djv147
|
[11]
|
Kirkup, B., McKee, A., Makin, K., et al. (2019) Perturbation of the Gut Microbiota by Antibiotics Results in Accelerated Breast Tumour Growth and Metabolic Dysregulation. https://doi.org/10.1101/553602
|
[12]
|
Zhu, J., Liao, M., Yao, Z., et al. (2018) Breast Cancer in Postmenopausal Women Is Associated with an Altered Gut Metagenome. Microbiome, 6, 136.
https://doi.org/10.1186/s40168-018-0515-3
|
[13]
|
Luu, T.H., Michel, C., Bard, J.M., et al. (2017) Intestinal Proportion of Blautia sp. Is Associated with Clinical Stage and Histoprognostic Grade in Patients with Early-Stage Breast Cancer. Nutrition and Cancer, 69, 267-275.
https://doi.org/10.1080/01635581.2017.1263750
|
[14]
|
Wu, A.H., Tseng, C., Vigen, C., et al. (2020) Gut Microbiome Associations with Breast Cancer Risk Factors and Tumor Characteristics: A Pilot Study. Breast Cancer Research and Treatment, 182, 451-463. https://doi.org/10.1007/s10549-020-05702-6
|
[15]
|
Fernández, M.F., Iris, R.-P., Manuel, A.J., et al. (2018) Breast Cancer and Its Relationship with the Microbiota. International Journal of Environmental Research and Public Health, 15, 1747. https://doi.org/10.3390/ijerph15081747
|
[16]
|
Mikó, E., Vida, A. and Bai, P. (2016) Translational Aspects of the Microbiome-To Be Exploited. Cell Biology and Toxicology, 32, 153-156.
https://doi.org/10.1007/s10565-016-9320-6
|
[17]
|
Tao, J., Li, S., Gan, R.Y., et al. (2020) Targeting Gut Microbiota with Dietary Components on Cancer: Effects and Potential Mechanisms of Action. Critical Reviews in Food Science and Nutrition, 60, 1025-1037.
https://doi.org/10.1080/10408398.2018.1555789
|
[18]
|
Chen, J.Q. and Yager, J.D. (2004) Estrogen’s Effects on Mitochondrial Gene Expression: Mechanisms and Potential Contributions to Estrogen Carcinogenesis. Annals of the New York Academy of Sciences, 1028, 258-272.
https://doi.org/10.1196/annals.1322.030
|
[19]
|
Samavat, H. and Kurzer, M.S. (2015) Estrogen Metabolism and Breast Cancer. Cancer Letters, 356, 231-243. https://doi.org/10.1016/j.canlet.2014.04.018
|
[20]
|
Key, T.J., Appleby, P.N., Reeves, G.K., et al. (2003) Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women. Journal of the National Cancer Institute, 95, 1218-1226. https://doi.org/10.1093/jnci/djg022
|
[21]
|
Sampson, J.N., Falk, R.T., Schairer, C., et al. (2017) Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women. Cancer Research, 77, 918-925. https://doi.org/10.1158/0008-5472.CAN-16-1717
|
[22]
|
Adlercreutz, H., Pulkkinen, M.O., Hamalainen, E.K., et al. (1984) Studies on the Role of Intestinal Bacteria in Metabolism of Synthetic and Natural Steroid Hormones. Journal of Steroid Biochemistry, 20, 217-229.
https://doi.org/10.1016/0022-4731(84)90208-5
|
[23]
|
Plottel, C.S. and Blaser, M.J. (2011) Microbiome and Malignancy. Cell Host & Microbe, 10, 324-335. https://doi.org/10.1016/j.chom.2011.10.003
|
[24]
|
Flores, R., Shi, J., Fuhrman, B., et al. (2012) Fecal Microbial Determinants of Fecal and Systemic Estrogens and Estrogen Metabolites: A Cross-Sectional Study. Journal of Translational Medicine, 10, Article No. 253.
https://doi.org/10.1186/1479-5876-10-253
|
[25]
|
Fuhrman, B.J., Feigelson, H.S., Flores, R., et al. (2014) Associations of the Fecal Microbiome with Urinary Estrogens and Estrogen Metabolites in Postmenopausal Women. The Journal of Clinical Endocrinology and Metabolism, 99, 4632-4640.
https://doi.org/10.1210/jc.2014-2222
|
[26]
|
Baker, J.M., Al-Nakkash, L. and Herbst-Kralovetz, M.M. (2017) Estrogen-Gut Microbiome Axis: Physiological and Clinical Implications. Maturitas, 103, 45-53.
https://doi.org/10.1016/j.maturitas.2017.06.025
|
[27]
|
Yang, J., Tan, Q., Fu, Q., et al. (2017) Gastrointestinal Microbiome and Breast Cancer: Correlations, Mechanisms and Potential Clinical Implications. Breast Cancer, 24, 220-228. https://doi.org/10.1007/s12282-016-0734-z
|
[28]
|
Dabek, M., McCrae, S.I., Stevens, V.J., et al. (2008) Distribution of Beta-Glucosidase and Beta-Glucuronidase Activity and of Beta-Glucuronidase Gene Gus in Human Colonic Bacteria. FEMS Microbiology Ecology, 66, 487-495.
https://doi.org/10.1111/j.1574-6941.2008.00520.x
|
[29]
|
McIntosh, F.M., Maison, N., Holtrop, G., et al. (2012) Phylogenetic Distribution of Genes Encoding β-Glucuronidase Activity in Human Colonic Bacteria and the Impact of Diet on Faecal Glycosidase Activities. Environmental Microbiology, 14, 1876-1887. https://doi.org/10.1111/j.1462-2920.2012.02711.x
|
[30]
|
Gloux, K., Berteau, O., El Oumami, H., et al. (2011) A Metagenomic β-Glucuronidase Uncovers a Core Adaptive Function of the Human Intestinal Microbiome. Proceedings of the National Academy of Sciences of the United States of America, 108, 4539-4546. https://doi.org/10.1073/pnas.1000066107
|
[31]
|
Crusz, S.M. and Balkwill, F.R. (2015) Inflammation and Cancer: Advances and New Agents. Nature Reviews Clinical Oncology, 12, 584-596.
https://doi.org/10.1038/nrclinonc.2015.105
|
[32]
|
Vogtmann, E. and Goedert, J.J. (2016) Epidemiologic Studies of the Human Microbiome and Cancer. British Journal of Cancer, 114, 237-242.
https://doi.org/10.1038/bjc.2015.465
|
[33]
|
Chassaing, B., Kumar, M., Baker, M.T., et al. (2014) Mammalian Gut Immunity. Biomedical Journal, 37, 246-258. https://doi.org/10.4103/2319-4170.130922
|
[34]
|
Buchta Rosean, C.M. and Rutkowski, M.R. (2017) The Influence of the Commensal Microbiota on Distal Tumor-Promoting Inflammation. Seminars in Immunology, 32, 62-73. https://doi.org/10.1016/j.smim.2017.06.002
|
[35]
|
Xuan, C., Shamonki, J.M., Chung, A., et al. (2014) Microbial Dysbiosis Is Associated with Human Breast Cancer. PLoS ONE, 9, e83744.
https://doi.org/10.1371/journal.pone.0083744
|
[36]
|
Lakritz, J.R., Poutahidis, T., Levkovich, T., et al. (2014) Beneficial Bacteria Stimulate Host Immune Cells to Counteract Dietary and Genetic Predisposition to Mammary Cancer in Mice. International Journal of Cancer, 135, 529-540.
https://doi.org/10.1002/ijc.28702
|
[37]
|
Peterson, D.A., McNulty, N.P., Guruge, J.L., et al. (2007) IgA Response to Symbiotic Bacteria as a Mediator of Gut Homeostasis. Cell Host & Microbe, 2, 328-339.
https://doi.org/10.1016/j.chom.2007.09.013
|
[38]
|
Goedert, J.J., Hua, X., Bielecka, A., et al. (2018) Postmenopausal Breast Cancer and Oestrogen Associations with the IgA-Coated and IgA-Noncoated Faecal Microbiota. British Journal of Cancer, 118, 471-479. https://doi.org/10.1038/bjc.2017.435
|
[39]
|
Sun, J., Furio, L., Mecheri, R., et al. (2015) Pancreatic β-Cells Limit Autoimmune Diabetes via an Immunoregulatory Antimicrobial Peptide Expressed under the Influence of the Gut Microbiota. Immunity, 43, 304-317.
https://doi.org/10.1016/j.immuni.2015.07.013
|
[40]
|
Chace, D. (2015) Turning Off Breast Cancer: A Personalized Approach to Nutrition and Detoxification in Prevention and Healing. Skyhorse Publishing, Inc., New York.
|
[41]
|
Rao, V.P., Poutahidis, T., Ge, Z., et al. (2006) Innate Immune Inflammatory Response against Enteric Bacteria Helicobacter hepaticus Induces Mammary Adenocarcinoma in Mice. Cancer Research, 66, 7395-7400.
https://doi.org/10.1158/0008-5472.CAN-06-0558
|
[42]
|
Vétizou, M., Pitt, J.M., Daillère, R., et al. (2015) Anticancer Immunotherapy by CTLA-4 Blockade Relies on the Gut Microbiota. Science, 350, 1079-1084.
https://doi.org/10.1126/science.aad1329
|
[43]
|
Gopalakrishnan, V., Spencer, C.N., Nezi, L., et al. (2018) Gut Microbiome Modulates Response to Anti-PD-1 Immunotherapy in Melanoma Patients. Science, 359, 97-103. https://doi.org/10.1126/science.aan4236
|
[44]
|
Sivan, A., Corrales, L., Hubert, N., et al. (2015) Commensal Bifidobacterium Promotes Antitumor Immunity and Facilitates Anti-PD-L1 Efficacy. Science, 350, 1084-1089. https://doi.org/10.1126/science.aac4255
|
[45]
|
Routy, B., Le Chatelier, E., Derosa, L., et al. (2018) Gut Microbiome Influences Efficacy of PD-1-Based Immunotherapy against Epithelial Tumors. Science, 359, 91-97.
https://doi.org/10.1126/science.aan3706
|
[46]
|
Rossi, T., Vergara, D., Fanini, F., et al. (2020) Microbiota-Derived Metabolites in Tumor Progression and Metastasis. International Journal of Molecular Sciences, 21, 5786. https://doi.org/10.3390/ijms21165786
|
[47]
|
Mikó, E., Kovács, T., Sebo, é., et al. (2019) Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored. Cells, 8, 293.
https://doi.org/10.3390/cells8040293
|
[48]
|
Thirunavukkarasan, M., Wang, C., Rao, A., et al. (2017) Short-Chain Fatty Acid Receptors Inhibit Invasive Phenotypes in Breast Cancer Cells. PLoS ONE, 12, e0186334.
https://doi.org/10.1371/journal.pone.0186334
|
[49]
|
Kiweler, N., Wünsch, D., Wirth, M., et al. (2020) Histone Deacetylase Inhibitors Dysregulate DNA Repair Proteins and Antagonize Metastasis-Associated Processes. Journal of Cancer Research and Clinical Oncology, 146, 343-356.
https://doi.org/10.1007/s00432-019-03118-4
|
[50]
|
Salimi, V., Shahsavari, Z., Safizadeh, B., et al. (2017) Sodium Butyrate Promotes Apoptosis in Breast Cancer Cells through Reactive Oxygen Species (ROS) Formation and Mitochondrial Impairment. Lipids in Health and Disease, 16, Article No. 208. https://doi.org/10.1186/s12944-017-0593-4
|
[51]
|
Ashida, H., Ogawa, M., Kim, M., et al. (2011) Bacteria and Host Interactions in the Gut Epithelial Barrier. Nature Chemical Biology, 8, 36-45.
https://doi.org/10.1038/nchembio.741
|
[52]
|
Rubin, R. (2019) High-Fiber Diet Might Protect against Range of Conditions. JAMA, 321, 1653-1655. https://doi.org/10.1001/jama.2019.2539
|
[53]
|
Vital, M., Howe, A.C. and Tiedje, J.M. (2014) Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta)genomic Data. mBio, 5, e00889.
https://doi.org/10.1128/mBio.00889-14
|
[54]
|
Zhao, L., Yang, R., Cheng, L., et al. (2011) LPS-Induced Epithelial-Mesenchymal Transition of Intrahepatic Biliary Epithelial Cells. Journal of Surgical Research, 171, 819-825. https://doi.org/10.1016/j.jss.2010.04.059
|
[55]
|
Kim, Y., Lee, E.J., Jang, H.K., et al. (2016) Statin Pretreatment Inhibits the Lipopolysaccharide-Induced Epithelial-Mesenchymal Transition via the Downregulation of Toll-Like Receptor 4 and Nuclear Factor-κB in Human Biliary Epithelial Cells. Journal of Gastroenterology and Hepatology, 31, 1220-1228.
https://doi.org/10.1111/jgh.13230
|
[56]
|
Zhu, G.H.Q., Huang, Y., Zheng, W., Hua, J., Yang, S., Zhuang, J., Wang, J. and Ye, J. (2016) Lipopolysaccharide Increases the Release of VEGF-C That Enhances Cell Motility and Promotes Lymphangiogenesis and Lymphatic Metastasis through the TLR4-NF-kB/JNK Pathways in Colorectal Cancer. Oncotarget, 7, 73711-73724.
https://doi.org/10.18632/oncotarget.12449
|
[57]
|
Costarelli, V. and Sanders, T.A. (2002) Plasma Deoxycholic Acid Concentration Is Elevated in Postmenopausal Women with Newly Diagnosed Breast Cancer. European Journal of Clinical Nutrition, 56, 925-927.
https://doi.org/10.1038/sj.ejcn.1601396
|
[58]
|
Zhu, Y., Zhu, M. and Lance, P. (2012) Stromal COX-2 Signaling Activated by Deoxycholic Acid Mediates Proliferation and Invasiveness of Colorectal Epithelial Cancer Cells. Biochemical and Biophysical Research Communications, 425, 607-612. https://doi.org/10.1016/j.bbrc.2012.07.137
|
[59]
|
Mikó, E., Vida, A., Kovács, T., et al. (2018) Lithocholic Acid, a Bacterial Metabolite Reduces Breast Cancer Cell Proliferation and Aggressiveness. Biochimica et Biophysica Acta—Bioenergetics, 1859, 958-974.
https://doi.org/10.1016/j.bbabio.2018.04.002
|
[60]
|
Kovács, T., Mikó, E., Vida, A., et al. (2019) Cadaverine, a Metabolite of the Microbiome, Reduces Breast Cancer Aggressiveness through Trace Amino Acid Receptors. Scientific Reports, 9, Article No. 1300.
https://doi.org/10.1038/s41598-018-37664-7
|
[61]
|
Zhu, Q., Jin, L., Casero, R.A., et al. (2012) Role of Ornithine Decarboxylase in Regulation of Estrogen Receptor Alpha Expression and Growth in Human Breast Cancer Cells. Breast Cancer Research and Treatment, 136, 57-66.
https://doi.org/10.1007/s10549-012-2235-x
|
[62]
|
Ward, H.A. and Kuhnle, G.G. (2010) Phytoestrogen Consumption and Association with Breast, Prostate and Colorectal Cancer in EPIC Norfolk. Archives of Biochemistry and Biophysics, 501, 170-175. https://doi.org/10.1016/j.abb.2010.05.018
|
[63]
|
Milder, I.E., Kuijsten, A., Arts, I.C., et al. (2007) Relation between Plasma Enterodiol and Enterolactone and Dietary Intake of Lignans in a Dutch Endoscopy-Based Population. Journal of Nutrition, 137, 1266-1271.
https://doi.org/10.1093/jn/137.5.1266
|
[64]
|
Pietinen, P., Stumpf, K., Mannisto, S., et al. (2001) Serum Enterolactone and Risk of Breast Cancer: A Case-Control Study in Eastern Finland. Cancer Epidemiology, Biomarkers & Prevention, 10, 339-344.
|
[65]
|
Saarinen, N.M., Warri, A., Airio, M., et al. (2007) Role of Dietary Lignans in the Reduction of Breast Cancer Risk. Molecular Nutrition & Food Research, 51, 857-866.
https://doi.org/10.1002/mnfr.200600240
|
[66]
|
Cotterchio, M., Boucher, B.A., Kreiger, N., et al. (2008) Dietary Phytoestrogen Intake—Lignans and Isoflavones—And Breast Cancer Risk (Canada). Cancer Causes & Control, 19, 259-272. https://doi.org/10.1007/s10552-007-9089-2
|
[67]
|
Parida, S. and Sharma, D. (2019) The Microbiome-Estrogen Connection and Breast Cancer Risk. Cells, 8, 1642. https://doi.org/10.3390/cells8121642
|
[68]
|
Roy, S. and Trinchieri, G. (2017) Microbiota: A Key Orchestrator of Cancer Therapy. Nature Reviews Cancer, 17, 271-285. https://doi.org/10.1038/nrc.2017.13
|
[69]
|
Alexander, J.L., Wilson, I.D., Teare, J., et al. (2017) Gut Microbiota Modulation of Chemotherapy Efficacy and Toxicity. Nature Reviews Gastroenterology & Hepatology, 14, 356-365. https://doi.org/10.1038/nrgastro.2017.20
|
[70]
|
Haiser, H.J. and Turnbaugh, P.J. (2013) Developing a Metagenomic View of Xenobiotic Metabolism. Pharmacological Research, 69, 21-31.
https://doi.org/10.1016/j.phrs.2012.07.009
|
[71]
|
Lehouritis, P., Cummins, J., Stanton, M., et al. (2015) Local Bacteria Affect the Efficacy of Chemotherapeutic Drugs. Scientific Reports, 5, Article No. 14554.
https://doi.org/10.1038/srep14554
|
[72]
|
Maier, I., Berry, D.M. and Schiestl, R.H. (2014) Intestinal Microbiota Reduces Genotoxic Endpoints Induced by High-Energy Protons. Radiation Research, 181, 45-53. https://doi.org/10.1667/RR13352.1
|
[73]
|
Touchefeu, Y., Montassier, E., Nieman, K., et al. (2014) Systematic Review: The Role of the Gut Microbiota in Chemotherapy- or Radiation-Induced Gastrointestinal Mucositis—Current Evidence and Potential Clinical Applications. Alimentary Pharmacology & Therapeutics, 40, 409-421. https://doi.org/10.1111/apt.12878
|
[74]
|
Yazdi, M.H., Soltan Dallal, M.M., Hassan, Z.M., et al. (2010) Oral Administration of Lactobacillus acidophilus Induces IL-12 Production in Spleen Cell Culture of BALB/c Mice Bearing Transplanted Breast Tumour. British Journal of Nutrition, 104, 227-232. https://doi.org/10.1017/S0007114510000516
|
[75]
|
Hassan, Z., Mustafa, S., Rahim, R.A., et al. (2016) Anti-Breast Cancer Effects of Live, Heat-Killed and Cytoplasmic Fractions of Enterococcus faecalis and Staphylococcus hominis Isolated from Human Breast Milk. In Vitro Cellular & Developmental Biology—Animal, 52, 337-348. https://doi.org/10.1007/s11626-015-9978-8
|
[76]
|
Toi, M., Hirota, S., Tomotaki, A., et al. (2013) Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-Control Study. Current Nutrition & Food Science, 9, 194-200.
https://doi.org/10.2174/15734013113099990001
|
[77]
|
Newman, T.M., Vitolins, M.Z. and Cook, K.L. (2019) From the Table to the Tumor: The Role of Mediterranean and Western Dietary Patterns in Shifting Microbial-Mediated Signaling to Impact Breast Cancer Risk. Nutrients, 11, 2565.
https://doi.org/10.3390/nu11112565
|
[78]
|
Xue, M., Ji, X., Liang, H., et al. (2018) The Effect of Fucoidan on Intestinal Flora and Intestinal Barrier Function in Rats with Breast Cancer. Food & Function, 9, 1214-1223.
https://doi.org/10.1039/C7FO01677H
|
[79]
|
Hullar, M.A., Burnett-Hartman, A.N. and Lampe, J.W. (2014) Gut Microbes, Diet, and Cancer. Cancer Treatment and Research, 159, 377-399.
https://doi.org/10.1007/978-3-642-38007-5_22
|